Prognostic Impacts of Additional Cytogenetic Abnormalities Acquired at the First Relapse in Adult Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplant in Second Complete Remission

被引：0
|
作者：
Shimizu, Hiroaki [1 ]
Mukae, Junichi [1 ]
Shingai, Naoki [1 ]
Toya, Takashi [1 ]
Najima, Yuho [2 ]
Kobayashi, Takeshi [1 ]
Hatsumi, Nahoko [3 ]
Takada, Satoru [3 ]
Handa, Hiroshi [4 ]
Haraguchi, Kyoko [5 ]
Okuyama, Yoshiki [5 ]
Sakamaki, Hisashi [1 ]
Ohashi, Kazuteru [1 ]
Doki, Noriko [1 ]
机构：
[1] Tokyo Metropolitan Canc & Infect Dis Ctr, Komagome Hosp, Div Hematol, Tokyo, Japan
[2] Tokyo Metropolitan Canc & Infect Dis Ctr, Div Hematol, Tokyo, Japan
[3] Saiseikai Maebashi Hosp, Leukemia Res Ctr, Gunma, Japan
[4] Gunma Univ Hosp, Dept Hematol, Maebashi, Gumma, Japan
[5] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Transfus & Cell Therapy, Tokyo, Japan
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-152621
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3380
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Extramedullary Disease at Diagnosis of Acute Myeloid Leukemia Does Not Influence Outcome of Patients Undergoing Allogeneic Hematopoietic Cell Transplant in First Complete Remission
    Michelis, Fotios V.
    Messner, Hans A.
    Alam, Naheed
    Gupta, Vikas
    Kim, Dennis Dong Hwan
    Kuruvilla, John
    Lambie, Anna
    Viswabandya, Auro
    Lipton, Jeffrey H.
    BLOOD, 2015, 126 (23)
  • [22] Cytogenetic Patterns of Relapse Following Stem Cell Transplantation in Morphologic Complete Remission in Patients with Cytogenetically Abnormal Acute Myeloid Leukemia
    Rashidi, Armin
    Cashen, Amanda
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S193 - S193
  • [23] Impact of Donor Age on Outcome of Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation in Complete Remission
    Hemmati, Philipp
    Terwey, Theis
    Na, Il-Kang
    Jehn, Christian
    Vuong, Lam
    le Coutre, Philipp
    Doerken, Bernd
    Arnold, Renate
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S203 - S203
  • [24] Effect of Allogeneic Hematopoietic Cell Transplant in First Complete Remission on Post-Relapse CR Rate and Survival in Acute Myeloid Leukemia
    Araki, Daisuke
    Othus, Megan
    Walter, Roland B.
    Sandmaier, Brenda M.
    Becker, Pamela S.
    Sandhu, Vicky
    Appelbaum, Frederick R.
    Estey, Elihu H.
    BLOOD, 2014, 124 (21)
  • [25] Differential Prognostic Relevance of Measurable Residual Disease in Acute Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation in First Versus Second Morphologic Remission
    Jentzsch, Madlen
    Kupper, Johannes
    Brauer, Dominic
    Backhaus, Donata
    Schulz, Julia
    Franke, Georg-Nikolaus
    Vucinic, Vladan
    Niederwieser, Dietger
    Platzbecker, Uwe
    Schwind, Sebastian
    BLOOD, 2021, 138
  • [26] Second allogeneic stem cell transplantation in acute lymphoblastic leukemia patients in second complete remission or relapse: A study on behalf of the ALWP / EBMT
    Nagler, Arnon
    Labopin, Myriam
    Finke, Juergen
    Brecht, Arne
    Schanz, Urs
    Niittyvuopio, Riitta
    Neubauer, Andreas
    Bornhaeuser, Martin
    Santarone, Stella
    Beelen, Dietrich
    Shimoni, Avichai
    Roesler, Wolf
    Peric, Zinaida
    Savani, Bipin N.
    Giebel, Sebastian
    Mohty, Mohamad
    BONE MARROW TRANSPLANTATION, 2019, 54 : 26 - 27
  • [27] Allogeneic stem cell transplant may improve the outcome of adult patients with inv(16) acute myeloid leukemia in first complete remission with poor molecular responses to chemotherapy
    Qin, Ya-Zhen
    Xu, Lan-Ping
    Chen, Huan
    Jiang, Qian
    Wang, Yu
    Jiang, Hao
    Zhang, Xiao-Hui
    Han, Wei
    Chen, Yu-Hong
    Wang, Feng-Rong
    Wang, Jing-Zhi
    Zhu, Hong-Hu
    Liu, Yan-Rong
    Jiang, Bin
    Liu, Kai-Yan
    Huang, Xiao-Jun
    LEUKEMIA & LYMPHOMA, 2015, 56 (11) : 3116 - 3123
  • [28] Allogeneic stem cell transplantation in second rather than first complete remission in selected patients with good-risk acute myeloid leukemia
    de Labarthe, A
    Pautas, C
    Thomas, X
    de Botton, S
    Bordessoule, D
    Tilly, H
    de Revel, T
    Bastard, C
    Preudhomme, C
    Michallet, M
    Fenaux, P
    Bastie, JN
    Socié, G
    Cordonnier, C
    Dombret, H
    BONE MARROW TRANSPLANTATION, 2005, 35 (08) : 767 - 773
  • [29] Allogeneic stem cell transplantation in second rather than first complete remission in selected patients with good-risk acute myeloid leukemia
    A de Labarthe
    C Pautas
    X Thomas
    S de Botton
    D Bordessoule
    H Tilly
    T de Revel
    C Bastard
    C Preudhomme
    M Michallet
    P Fenaux
    J-N Bastie
    G Socié
    C Cordonnier
    H Dombret
    Bone Marrow Transplantation, 2005, 35 : 767 - 773
  • [30] Duration of second complete remission compared with first complete remission in patients with acute myeloid leukemia
    Lee, S
    Tallman, MS
    Oken, MM
    Cassileth, PA
    Bennett, JM
    Wiernik, PH
    Rowe, JM
    LEUKEMIA, 2000, 14 (08) : 1345 - 1348
12345